SPARCL1 and metabolic dysfunction-associated steatotic liver disease: Compared with healthy controls, lncSPARCL1-1:2 was upregulated in NAFLD, simple steatosis, and NASH, and lnc-SPARCL1-1:2 was an independent predictor of NASH.